Table 3 Clinical, histological and molecular data of the ALK, ROS1 or RET translocated cases.

From: An improved assay for detection of theranostic gene translocations and MET exon 14 skipping in thoracic oncology

Case

Sex

Age

Sample

Location

Histology

Tumor cells %

Routine IHC / FISH

LD-RT-PCR

5′ transcript

3′ transcript

ALK-A

M

86

RS

L

ADC

50–100

+/+

+

EML4 exon 2

ALK exon 20

ALK-B

M

65

RS

L

ADC

25–50

+/+

EML4 exon 13

ALK exon 20

ALK-C

F

46

BB

L

ADC

15–25

+/+

+

EML4 exon 13

ALK exon 20

ALK-D

M

72

BB

L

ADC

5–15

+/+

+

EML4 exon 13

ALK exon 20

ALK-E

F

54

RS

L

ADC

25–50

+/+

+

EML4 exon 13

ALK exon 20

ALK-F

M

61

BB

L

ADC

25–50

+/+

+

EML4 exon 13

ALK exon 20

ALK-G

F

86

BB

L

ADC

15–25

+/+

+

EML4 exon 6

ALK exon 20

ALK-H

F

28

SR

P

ADC

15–25

+/+

+

EML4 exon 13

ALK exon 20

ALK-I

M

77

BB

L

ADC

15–25

+/+

+

EML4 exon 17

ALK exon 20

ALK-J

M

66

BB

L

ADC

15–25

+/+

+

EML4 exon 6

ALK exon 20

ALK-K

F

83

RS

L

ADC

50–100

+/+

+

EML4 exon 13

ALK exon 20

ALK-L

M

75

RS

L

ADC

0–5

+/+

+

EML4 exon 6

ALK exon 20

ALK-M

M

71

BB

L

ADC

15–25

+/+

+

HIP1 exon 21

ALK exon 20

ALK-N

M

68

RS

L

ADC

50–100

+/+

+

EML4 exon 18

ALK exon 20

ALK-O

F

44

SR

LN

ADC

25–50

+/+

+

EML4 exon 13

ALK exon 20

ALK-P

F

44

RS

L

ADC

25–50

+/+

+

EML4 exon 13

ALK exon 20

ALK-Q

M

64

SR

P

ADC

15–25

+/+

EML4 exon 7

ALK exon 20

ALK-R

F

68

RS

L

ADC

25–50

+/+

TRIM24 exon 12

ALK exon 20

ROS1-A

F

85

RS

L

ADC

50–100

+/+

+

EZR1 exon 10

ROS1 exon 32

ROS1-B

F

52

SR

P

ADC

50–100

+/+

+

CD74 exon 6

ROS1 exon 34

ROS1-C

M

97

SR

P

ADC

0–5

+/+

+

CD74 exon 6

ROS1 exon 32

ROS1-D

F

60

SR

P

ADC

15–25

+/+

+

SDC4 exon 2

ROS1 exon 32

RET-A

F

38

SR

LN

ADC

15–25

NA

+

KIF5B exon 15

RET exon 12

RET-B

M

65

BB

L

ADC

15–25

NA

+

CCDC6 exon 1

RET exon 12

  1. Cases ALK-O and ALK-P are from the same patient. Age is indicated in years.
  2. M male, F female, RS resection specimen, BB bronchial biopsy, SB surgical biopsy, L lung, P pleura, LN lymph node, ADC adenocarcinoma, + positive, − negative, NA not applicable.